X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.83 -0.07 (-2.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Preferred Stock Liabilities (2017 - 2021)

Updated

X4 Pharmaceuticals' Preferred Stock Liabilities was $1.88 million in Q2 2021, unchanged from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Preferred Stock Liabilities (2017 - 2021) Analysis & Trends

At the end of FY2018, Preferred Stock Liabilities at X4 Pharmaceuticals came in at $64.68 million, up 4.9% from FY2017.

  • In earlier years, Preferred Stock Liabilities was $61.64 million in FY2017 (+75.9%) and $35.04 million in FY2016.
  • Quarterly Preferred Stock Liabilities has moved between $1.88 million (Q1 2021) and $64.68 million (Q4 2018) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 X4 Pharmaceuticals 366.40 Mn -332.29 Mn 7.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 1.88 Mn
Mar 31, 2021 1.88 Mn
Dec 31, 2018 64.68 Mn
Sep 30, 2018 64.68 Mn
Jun 30, 2018 60.39 Mn
Mar 31, 2018 60.39 Mn
Dec 31, 2017 61.64 Mn
API Access

X4 Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=XFOR&period=max&api_key=YOUR_API_KEY